Objective: It is known that exogenous lactate given as an i.v. energy infusion is able to counteract a neuroglycopenic state that developed during psychosocial stress. It is unknown, however, whether the brain under stressful conditions can induce a rise in plasma lactate to satisfy its increased needs during stress. Since lactate is i) an alternative cerebral energy substrate to glucose and ii) its plasmatic concentration is influenced by the sympathetic nervous system, the present study aimed at investigating whether plasma lactate concentrations increase with psychosocial stress in humans. Methods:30 healthy young men participated in two sessions (stress induced by the Trier Social Stress Test and a non-stress control session). Blood samples were frequently taken to assess plasma lactate concentrations and stress hormone profiles. Results: Plasma lactate increased 47% during psychosocial stress (from 0.9 ± 0.05 to 1.4 ± 0.1 mmol/l; interaction time × stress intervention: F = 19.7, p < 0.001). This increase in lactate concentrations during stress was associated with an increase in epinephrine (R2 = 0.221, p = 0.02) and ACTH concentrations (R2 = 0.460, p < 0.001). Conclusion: Plasma lactate concentrations increase during acute psychosocial stress in humans. This finding suggests the existence of a demand mechanism that functions to allocate an additional source of energy from the body towards the brain, which we refer to as ‘cerebral lactate demand’.

Keywords:
Brain-pull, Cerebral lactate demand, Social stress
1.
Peters A, Kubera B, Hubold C, Langemann D: The selfish brain: stress and eating behavior. Front Neurosci 2011;5:74.
2.
Peters A, Langemann D: Build-ups in the supply chain of the brain: on the neuroenergetic cause of obesity and type 2 diabetes mellitus. Front Neuroenergetics 2009;doi:10.3389/neuro.14.002.2009.
3.
Peters A, Bosy-Westphal A, Kubera B, Langemann D, Goele K, Later W, Heller M, Hubold C, Müller MJ: Why doesn’t the brain lose weight, when obese people diet? Obes Facts 2011;4 :151–157.
4.
Peters A, Schweiger U, Pellerin L, Hubold C, Oltmanns KM, Conrad M, Schultes B, Born J, Fehm HL: The selfish brain: competition for energy resources. Neurosci Biobehav Rev 2004;28:143–180.
5.
Peters A, Pellerin L, Dallman MF, Oltmanns KM, Schweiger U, Born J, Fehm HL: Causes of obesity: looking beyond the hypothalamus. Prog Neurobiol 2007;81:61–88.
6.
Madsen PL, Hasselbalch SG, Hagemann LP, Olsen KS, Bulow J, Holm S, Widschiodtz G, Paulson OB, Lassen NA: Persistent resetting of the cerebral oxygen/glucose uptake ratio by brain activation: evidence obtained with the Kety-Schmidt technique. J Cereb Blood Flow Metab 1995;15:485–491.
7.
Hitze B, Hubold C, van Dyken R, Schlichting K, Lehnert H, Entringer S, Peters A: How the selfish brain organizes its ‘supply and demand’. Front Neuroenergetics 2010;doi: 10.3389/fnene.2010.00007.
8.
Ahren B: Autonomic regulation of islet hormone secretion – implications for health and disease. Diabetologia 2000;43:393–410.
9.
Woods SC, Porte D Jr: Neural control of the endocrine pancreas. Physiol Rev 1974;54:596–619.
10.
Billaudel B, Sutter BC: Immediate in-vivo effect of corticosterone on glucose-induced insulin secretion in the rat. J Endocrinol 1982;95:315–320.
11.
Seaquist ER, Damberg GS, Tkac I, Gruetter R: The effect of insulin on in vivo cerebral glucose concentrations and rates of glucose transport/metabolism in humans. Diabetes 2001;50:2203–2209.
12.
Hasselbalch SG, Knudsen GM, Jakobsen J, Hageman LP, Holm S, Paulson OB: Blood-brain barrier permeability of glucose and ketone bodies during short-term starvation in humans. Am J Physiol 1995;268:E1161–E1166.
13.
James JH, Wagner KR, King JK, Leffler RE, Upputuri RK, Balasubramaniam A, Friend LA, Shelly DA, Paul RJ, Fischer JE: Stimulation of both aerobic glycolysis and Na(+)-K(+)-ATPase activity in skeletal muscle by epinephrine or amylin. Am J Physiol 1999;277:E176–E186.
14.
Hamann JJ, Kelley KM, Gladden LB: Effect of epinephrine on net lactate uptake by contracting skeletal muscle. J Appl Physiol 2001;91:2635–2641.
15.
Meyer C, Saar P, Soydan N, Eckhard M, Bretzel RG, Gerich J, Linn T: A potential important role of skeletal muscle in human counterregulation of hypoglycemia. J Clin Endocrinol Metab 2005;90:6244–6250.
16.
Gladden LB: Lactate metabolism: a new paradigm for the third millennium. J Physiol 2004;558:5–30.
17.
Goodwin ML, Harris JE, Hernandez A, Gladden LB: Blood lactate measurements and analysis during exercise: a guide for clinicians. J Diabetes Sci Technol 2007;1:558–569.
18.
Qu H, Haberg A, Haraldseth O, Unsgard G, Sonnewald U: (13)C MR spectroscopy study of lactate as substrate for rat brain. Dev Neurosci 2000;22:429–436.
19.
Bouzier-Sore AK, Voisin P, Canioni P, Magistretti PJ, Pellerin L: Lactate is a preferential oxidative energy substrate over glucose for neurons in culture. J Cereb Blood Flow Metab 2003;23:1298–1306.
20.
Smith D, Pernet A, Hallett WA, Bingham E, Marsden PK, Amiel SA: Lactate: a preferred fuel for human brain metabolism in vivo. J Cereb Blood Flow Metab 2003;23:658–664.
21.
Pellerin L, Magistretti PJ: Food for thought: challenging the dogmas. J Cereb Blood Flow Metab 2003;23:1282–1286.
22.
Cureton EL, Kwan RO, Dozier KC, Sadjadi J, Pal JD, Victorino GP: A different view of lactate in trauma patients: protecting the injured brain. J Surg Res 2010;159:468–473.
23.
Hall JB, Brown DA: Plasma glucose and lactic acid alterations in response to a stressful exam. Biol Psychol 1979;8:179–188.
24.
Kirschbaum C, Pirke KM, Hellhammer DH: The ‘Trier Social Stress Test’ – a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 1993;28:76–81.
25.
Parolin ML, Chesley A, Matsos MP, Spriet LL, Jones NL, Heigenhauser GJ: Regulation of skeletal muscle glycogen phosphorylase and PDH during maximal intermittent exercise. Am J Physiol 1999;277:E890–E900.
26.
Pierre K, Pellerin L: Monocarboxylate transporters in the central nervous system: distribution, regulation and function. J Neurochem 2005;94:1–14.
27.
Ide K, Horn A, Secher NH: Cerebral metabolic response to submaximal exercise. J Appl Physiol 1999;87:1604–1608.
28.
Maran A, Cranston I, Lomas J, Macdonald I, Amiel SA: Protection by lactate of cerebral function during hypoglycaemia. Lancet 1994;343:16–20.
29.
van Dyken R, Hubold C, Meier S, Hitze B, Marxsen A, Oltmanns KM, Schweiger U, Lehnert H, Pellerin L, Peters A: Low plasma lactate concentrations as a biomarker of an incompetent brain pull: a risk factor for weight gain in type 2 diabetes patients. Psychoendocrinology 2010;35:1287–1293.
30.
Flaa A, Sandvik L, Kjeldsen SE, Eide IK, Rostrup M: Does sympathoadrenal activity predict changes in body fat? An 18-y follow-up study. Am J Clin Nutr 2008;87:1596–1601.
31.
Eliakim A, Nemet D, Zaldivar F, McMurray RG, Culler FL, Galassetti P, Cooper DM: Reduced exercise-associated response of the GH-IGF-I axis and catecholamines in obese children and adolescents. J Appl Physiol 2006;100:1630–1637.
32.
Nielsen B, Astrup A, Samuelsen P, Wengholt H, Christensen NJ: Effect of physical training on thermogenic responses to cold and ephedrine in obesity. Int J Obes Relat Metab Disord 1993;17:383–390.
33.
Spraul M, Anderson EA, Bogardus C, Ravussin E: Muscle sympathetic nerve activity in response to glucose ingestion. Impact of plasma insulin and body fat. Diabetes 1994;43:191–196.
34.
Tkacs NC, Levin BE: Obesity-prone rats have preexisting defects in their counterregulatory response to insulin-induced hypoglycemia. Am J Physiol Regul Integr Comp Physiol 2004;287:R1110–R1115.
35.
Shin AC, MohanKumar SM, Sirivelu MP, Claycombe KJ, Haywood JR, Fink GD; MohanKumar PS: Chronic exposure to a high-fat diet affects stress axis function differentially in diet-induced obese and diet-resistant rats. Int J Obes (Lond) 2010;37:1218–1226.
36.
Levin BE, Richard D, Michel C, Servatius R: Differential stress responsivity in diet-induced obese and resistant rats. Am J Physiol Regul Integr Comp Physiol 2000;279:R1357–R1364.
© 2012 S. Karger GmbH, Freiburg
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.